Novel molecules applied as immunomodulatory agents in sepsis are thymosin-1 (T-1) and ulinastatin. T-1 is a naturally occurring thymic peptide used worldwide for the treatment of certain viral ...
TAK-671, also known as SB26, is an ulinastatin-FC (UTI-Fc) fusion protein, which has already been tested in preclinical trials in monkeys and rats. The randomised, double-blind, placebo-controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback